| Literature DB >> 9350775 |
C C Daly1, I Hoffman, M Hobbs, M Maida, D Zimba, R Davis, G Mughogho, M S Cohen.
Abstract
Susceptibility of Neisseria gonorrhoeae to gentamicin, the primary treatment for gonorrhea in Malawi since 1993, was determined by using agar dilution MICs, E-test MICs, disc diffusion, and clinical cure rate. Agar dilution MICs were slightly higher in 1996 than in 1993 isolates, with a concomitant drop in the clinical cure rate. E-test MICs were substantially lower than agar dilution determinations, with only 77.4% within 1 log2 concentration.Entities:
Keywords: Africa; Africa South Of The Sahara; Antibiotics; Clinical Research; Developing Countries; Diseases; Drugs; Eastern Africa; English Speaking Africa; Examinations And Diagnoses; Gonorrhea; Infections; Laboratory Examinations And Diagnoses; Laboratory Procedures; Malawi; Reproductive Tract Infections; Research Methodology; Research Report; Sexually Transmitted Diseases; Treatment
Mesh:
Substances:
Year: 1997 PMID: 9350775 PMCID: PMC230103 DOI: 10.1128/jcm.35.11.2985-2988.1997
Source DB: PubMed Journal: J Clin Microbiol ISSN: 0095-1137 Impact factor: 5.948